Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Strikes Agreement for Cheaper Reagents for New York Biomedicine

NEW YORK, Nov. 14-AMDeC Foundation, New York's biomedical umbrella organization, has arranged a discounted supplier relationship with PerkinElmer for microarray reagents.


Under the arrangement, PerkinElmer will supply non-radioactive labeled nucleotide analogs, including cyanine- and biotin-labeled nucleotides, to the 39 AMDeC member institutions at "significant" savings.


The company would not provide specific or ballpark figures on the discount.


AMDeC (the "Academic Medical Development Corporation") promotes biomedical research in New York. Its members include Cold Spring Harbor Labs, the State University of New York at Buffalo, Rockefeller University, Memorial Sloan-Kettering Cancer Center, and other institutes and hospitals.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.